Prostate-Specific Antigen as an Estimator of Prostate Volume in the Management of Patients with Symptomatic Benign Prostatic Hyperplasia
- 31 December 2003
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 44 (6), 695-700
- https://doi.org/10.1016/s0302-2838(03)00384-1
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Prediction of prostate volume based on total and free serum prostate-specific antigen: is it reliable?European Urology, 2000
- SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 2000
- Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasiaUrology, 1999
- Relationship among age, prostate-specific antigen, and prostate volume in men with lower urinary tract symptoms (LUTS) and in different groups of men with and without benign and malignant prostate diseasesThe Prostate, 1998
- Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trialsUrology, 1996
- Prostate specific antigen in a community‐based sample of men without prostate cancer: Correlations with prostate volume, age, body mass index, and symptoms of prostatismThe Prostate, 1995
- Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference rangesJAMA, 1993
- Relationship between Prostate Specific Antigen, Prostate Volume and Age in the Benign ProstateBJU International, 1993
- The Distribution of Prostate Specific Antigen in Men Without Clinical or Pathological Evidence of Prostate Cancer: Relationship to Gland Volume and AgeJournal of Urology, 1992
- Prostate‐specific antigen lewels in 1695 men without evidence of prostate cancer: Findings of the American cancer society national prostate cancer detection projectCancer, 1992